Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an autologous blood transfusion procedure used as a research intervention by the Centre Hospitalier Universitaire Vaudois (CHUV). The procedure involves the collection, storage, and subsequent re-infusion of a subject's own blood. In the context of the specific clinical study (NCT04014153), the blood is stored in specialized DEHP-free blood bags containing alternative plasticizers like n-butyryl-tri-(n-hexyl)-citrate (BTHC). The primary objective of this research is to identify biomarkers in various matrices (blood, urine) that can detect autologous blood transfusions for anti-doping purposes, particularly when traditional markers like DEHP metabolites are absent due to the use of DEHP-free storage materials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous blood transfusion-Centre Hospitalier Universitaire Vaudois.